- Home
- ENTX vs LVO Comparison
ENTX vs LVO Comparison
Compare ENTX & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- LVO
- Stock Information
- Founded
- ENTX 2010
- LVO 2009
- Country
- ENTX Israel
- LVO United States
- Employees
- ENTX 21
- LVO N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- LVO Restaurants
- Sector
- ENTX Health Care
- LVO Consumer Discretionary
- Exchange
- ENTX Nasdaq
- LVO Nasdaq
- Market Cap
- ENTX 91.3M
- LVO 82.1M
- IPO Year
- ENTX 2018
- LVO N/A
- Fundamental
- Price
- ENTX $2.00
- LVO $0.64
- Analyst Decision
- ENTX Strong Buy
- LVO Strong Buy
- Analyst Count
- ENTX 1
- LVO 1
- Target Price
- ENTX $10.00
- LVO $1.50
- AVG Volume (30 Days)
- ENTX 294.0K
- LVO 603.5K
- Earning Date
- ENTX 08-08-2025
- LVO 08-13-2025
- Dividend Yield
- ENTX N/A
- LVO N/A
- EPS Growth
- ENTX N/A
- LVO N/A
- EPS
- ENTX N/A
- LVO N/A
- Revenue
- ENTX $166,000.00
- LVO $100,534,000.00
- Revenue This Year
- ENTX N/A
- LVO N/A
- Revenue Next Year
- ENTX N/A
- LVO $18.93
- P/E Ratio
- ENTX N/A
- LVO N/A
- Revenue Growth
- ENTX 191.23
- LVO N/A
- 52 Week Low
- ENTX $1.50
- LVO $0.55
- 52 Week High
- ENTX $2.79
- LVO $1.82
- Technical
- Relative Strength Index (RSI)
- ENTX 54.00
- LVO 41.69
- Support Level
- ENTX $1.87
- LVO $0.59
- Resistance Level
- ENTX $2.14
- LVO $0.72
- Average True Range (ATR)
- ENTX 0.10
- LVO 0.04
- MACD
- ENTX 0.00
- LVO 0.00
- Stochastic Oscillator
- ENTX 60.00
- LVO 36.21
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.